Multiple myeloma treated with mitoxantrone in combination with vincristine and prednisolone (NOP regimen) versus melphalan and prednisolone: a phase III study-Reference-Cited by-同舟云学术

Multiple myeloma treated with mitoxantrone in combination with vincristine and prednisolone (NOP regimen) versus melphalan and prednisolone: a phase III study

Published:2009-04-24 Issue:2 Volume:51 Page:80-85
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Keldsen Nina,Bjerrum Ole Weis,Dahl Inger Marie S.,Drivsholm Aage,Ellegaard Jørgen,Gadeberg Ole,Gimsing Peter,Grønvold Trude,Hansen Mogens Mørk,Hippe Erik,Lamvik Jon,Ly Bernt,Skarbøvik Alv,Talstad Ingebrigt,Thorling Karen,Wesenberg Karl,

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.1993.tb01597.x/fullpdf

Reference13 articles.

1. Chemotherapy of multiple myeloma;Durie;Baillire's Clinical Haematology,1991

2. Effective treatment of advanced multiple myeloma refractory to alkylating agents;Barlogie;New Engl J Med,1984

3. Combination chemotherapy with vincristine, doxorubicin, dexamethasone for refractory or relapsing multiple myeloma;Monconduit;B J Haematol,1986

4. The efficacy and toxicity of VAD in the treatment of myeloma and related disorders;Sheehan;Scand J Haematol,1986

5. Resistant multiple myeloma treated with mitoxantrone in combination with vincristine and prednisolone (NOP-regime);Hippe;Eur J Haematol,1987

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nordic Myeloma Study Group, the first 15 years: scientific collaboration and improvement of patient care;European Journal of Haematology;2005-03

2. Melphalan and Prednisone (MP) Regimen for Multiple Myeloma;Hospital Pharmacy;2004-04

3. DIAGNOSIS, PROGNOSIS, AND STANDARD TREATMENT OF MULTIPLE MYELOMA;Hematology/Oncology Clinics of North America;1997-02